Understanding how molecules interact in cancer
Official title: Center for Molecular Interactions in Cancer (CMIC)
Funded at Univ of Arkansas for Med Scis · NIH-11049024 · Data updated 2026-11-12
This study is looking at how tiny molecules in our bodies can lead to cancer, and it's for anyone interested in understanding more about cancer and how to improve treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Arkansas for Med Scis NIH-funded |
| Lab location | 1 site (Little Rock, United States) |
| Project start | March 5, 2024 |
| Project end | December 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $2,065,501 |
| NIH project number | 5P20GM152281-02 |
| Project ID | NIH-11049024 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with various types of cancer who are seeking innovative treatment options.
✕Less likely to help
Patients with non-cancerous conditions or those not diagnosed with cancer may not receive any benefit from this research.
What this research studies
This research focuses on the molecular mechanisms that contribute to cancer development and progression. By establishing the Center for Molecular Interactions in Cancer (CMIC) at the University of Arkansas for Medical Sciences, the team aims to explore the structural biology and biochemical processes that drive cancer. The research will involve high-resolution imaging and quantitative analysis to uncover how these molecular interactions influence cancer treatment and patient outcomes. The center will also support junior investigators and foster collaboration among researchers.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer therapies and better patient outcomes.
How similar studies have gone: Previous research in molecular interactions and cancer biology has shown promising results, indicating that this approach could lead to significant advancements in cancer treatment.
Where this research is happening
-
Univ of Arkansas for Med Scis
Little Rock, United States Active
Researchers
- Principal investigator: Eoff, Robert L — Univ of Arkansas for Med Scis
- Study coordinator: Eoff, Robert L
Related research
Other NIH-funded projects on the same topics.
-
Postpartum depression screening at well-child visits in Arkansas
A study examines whether adding depression screening at baby visits in Arkansas improves detection and care for new mothers.
-
How the RORα protein affects breast cancer growth and inflammation
Researchers are looking at whether boosting the RORα protein in breast cells can lower harmful oxidative stress and immune inflammation that help breast cancer grow.
-
PLOD2 and succinate: a metabolic switch that fuels breast cancer spread
A cancer research project is exploring how a metabolic change involving succinate and a key enzyme (PLOD2) may drive breast cancer cells to become more invasive and able to spread.
-
Stopping steroid-related muscle and bone wasting in Duchenne muscular dystrophy
Researchers are testing ways to protect muscles and bones in people with Duchenne muscular dystrophy who take long-term steroid medicines.
-
STAR+ Model for Hearing Diagnostics and Treatment in Rural Appalachian Children
A program that uses telehealth to connect rural school children with hearing specialists so they can get timely testing and treatment for hearing loss.
-
Organoid model to study how malaria and EBV drive Burkitt lymphoma in children
A study uses human tonsillar organoids to understand how malaria parasite infection and EBV together may cause a type of lymphoma in children from sub-Saharan Africa.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.